Journal article icon

Journal article

Evidence for prolonged clinical benefit from initial combination antiretroviral therapy: Delta extended follow-up.

Abstract:

BACKGROUND: The findings from therapeutic trials in HIV infection with surrogate endpoints based on laboratory markers are only partially relevant for clinical decisions on treatment. Although the collection of clinical follow-up data from such a trial would be relatively straightforward, this rarely occurs. An important reason for this may be the perception that such data have little value because the number of participants remaining on their original allocated therapy has usually fallen su...

Expand abstract

Actions


Access Document


Authors


Delta Coordinating Committee More by this author
Journal:
HIV medicine
Volume:
2
Issue:
3
Pages:
181-188
Publication date:
2001-07-05
DOI:
EISSN:
1468-1293
ISSN:
1464-2662
URN:
uuid:a3779c26-20cf-4f91-9659-ef4e1be7840c
Source identifiers:
196498
Local pid:
pubs:196498

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP